Review of the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial: Warfarin versus dabigatran

被引：2
|
作者：
Ingelmo C. [1 ]
Wazni O. [1 ]
机构：
[1] Cleveland Clinic Foundation, Cleveland, OH 44195
来源：
Current Cardiology Reports | 2011年 / 13卷 / 5期
关键词：
Anticoagulation therapy; Atrial fibrillation; Dabigatran; RE-LY trial; Warfarin;
D O I：
10.1007/s11886-011-0203-4
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：357 / 360
页数：3
相关论文
共 50 条
  • [1] Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial
    Dans, Antonio L.
    Connolly, Stuart J.
    Wallentin, Lars
    Yang, Sean
    Nakamya, Juliet
    Brueckmann, Martina
    Ezekowitz, Michael
    Oldgren, Jonas
    Eikelboom, John W.
    Reilly, Paul A.
    Yusuf, Salim
    [J]. CIRCULATION, 2013, 127 (05) : 634 - 640
  • [2] Personalizing the decision of dabigatran versus warfarin in atrial fibrillation: A secondary analysis of the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) trial
    Reinhardt, Samuel W.
    Desai, Nihar R.
    Tang, Yuanyuan
    Jones, Philip G.
    Ader, Jeremy
    Spertus, John A.
    [J]. PLOS ONE, 2021, 16 (08):
  • [3] Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial
    Healey, Jeff S.
    Eikelboom, John
    Douketis, James
    Wallentin, Lars
    Oldgren, Jonas
    Yang, Sean
    Themeles, Ellison
    Heidbuchle, Hein
    Avezum, Alvaro
    Reilly, Paul
    Connolly, Stuart J.
    Yusuf, Salim
    Ezekowitz, Michael
    [J]. CIRCULATION, 2012, 126 (03) : 343 - 348
  • [4] Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial
    Hohnloser, Stefan H.
    Oldgren, Jonas
    Yang, Sean
    Wallentin, Lars
    Ezekowitz, Michael
    Reilly, Paul
    Eikelboom, John
    Brueckmann, Martina
    Yusuf, Salim
    Connolly, Stuart J.
    [J]. CIRCULATION, 2012, 125 (05) : 669 - 676
  • [5] Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran
    Ezekowitz, Michael D.
    Connolly, Stuart
    Parekh, Amit
    Reilly, Paul A.
    Varrone, Jeanne
    Wang, Susan
    Oldgren, Jonas
    Themeles, Ellison
    Wallentin, Lars
    Yusuf, Salim
    [J]. AMERICAN HEART JOURNAL, 2009, 157 (05) : 805 - 810
  • [6] The RE-LY study: Randomized Evaluation of Long-term anticoagulant therapY: dabigatran vs. warfarin
    Camm, A. John
    [J]. EUROPEAN HEART JOURNAL, 2009, 30 (21) : 2554 - 2555
  • [7] "Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial" Response
    Healey, Jeff S.
    Eikelboom, John
    Yang, Sean
    Themeles, Ellison
    Connolly, Stuart J.
    Yusuf, Salim
    Douketis, James
    Wallentin, Lars
    Oldgren, Jonas
    Heidbuchel, Hein
    Avezum, Alvaro
    Reilly, Paul
    Ezekowitz, Michael
    [J]. CIRCULATION, 2013, 127 (11) : E506 - E506
  • [8] Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial (vol 127, pg 634, 2013)
    Dans, A. L.
    [J]. CIRCULATION, 2013, 127 (14) : E542 - E542
  • [9] Reasons for hospitalization and risk of mortality in patients with atrial fibrillation treated with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial
    Alak, Aiman
    Hohnloser, Stefan H.
    Fraessdorf, Mandy
    Reilly, Paul
    Ezekowitz, Michael
    Healey, Jeff S.
    Brueckmann, Martina
    Yusuf, Salim
    Connolly, Stuart J.
    [J]. EUROPACE, 2019, 21 (07): : 1023 - 1038
  • [10] Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy)
    Ezekowitz, Michael D.
    Nagarakanti, Rangadham
    Noack, Herbert
    Brueckmann, Martina
    Litherland, Claire
    Jacobs, Mark
    Clemens, Andreas
    Reilly, Paul A.
    Connolly, Stuart J.
    Yusuf, Salim
    Wallentin, Lars
    [J]. CIRCULATION, 2016, 134 (08) : 589 - 598
12345